Correlation Between Tenaya Therapeutics and Stoke Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tenaya Therapeutics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenaya Therapeutics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenaya Therapeutics and Stoke Therapeutics, you can compare the effects of market volatilities on Tenaya Therapeutics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenaya Therapeutics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenaya Therapeutics and Stoke Therapeutics.

Diversification Opportunities for Tenaya Therapeutics and Stoke Therapeutics

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tenaya and Stoke is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Tenaya Therapeutics and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Tenaya Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenaya Therapeutics are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Tenaya Therapeutics i.e., Tenaya Therapeutics and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between Tenaya Therapeutics and Stoke Therapeutics

Given the investment horizon of 90 days Tenaya Therapeutics is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tenaya Therapeutics is 1.05 times less risky than Stoke Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,028  in Stoke Therapeutics on August 28, 2024 and sell it today you would earn a total of  150.00  from holding Stoke Therapeutics or generate 14.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tenaya Therapeutics  vs.  Stoke Therapeutics

 Performance 
       Timeline  
Tenaya Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tenaya Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Tenaya Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Tenaya Therapeutics and Stoke Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tenaya Therapeutics and Stoke Therapeutics

The main advantage of trading using opposite Tenaya Therapeutics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenaya Therapeutics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.
The idea behind Tenaya Therapeutics and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital